Global Antivirals Market Research Report 2025(Status and Outlook)
Antiviral drugs are a class of medication used specifically for treating viral infections rather than bacterial ones. Most antivirals are used for specific viral infections, while a broad-spectrum antiviral is effective against a wide range of viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
The global Antivirals market size was estimated at USD 44620.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 0.04% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antivirals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antivirals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antivirals market.
Global Antivirals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy?s
Market Segmentation (by Type)
Generic
Branded
Market Segmentation (by Application)
HIV
Hepatitis
HSV
Influenza
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antivirals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antivirals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Antivirals market size was estimated at USD 44620.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 0.04% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Antivirals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Antivirals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Antivirals market.
Global Antivirals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Johnson & Johnson
Teva Pharmaceutical Industries
GSK
Mylan
Gilead Sciences
F. Hoffmann-La Roche
Bristol-Myers-Squibb
AbbVie
Aurobindo Pharma
Cipla
Dr Reddy?s
Market Segmentation (by Type)
Generic
Branded
Market Segmentation (by Application)
HIV
Hepatitis
HSV
Influenza
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Antivirals Market
- Overview of the regional outlook of the Antivirals Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antivirals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Antivirals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antivirals
1.2 Key Market Segments
1.2.1 Antivirals Segment by Type
1.2.2 Antivirals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIVIRALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antivirals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Antivirals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIVIRALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Antivirals Product Life Cycle
3.3 Global Antivirals Sales by Manufacturers (2020-2025)
3.4 Global Antivirals Revenue Market Share by Manufacturers (2020-2025)
3.5 Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antivirals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Antivirals Market Competitive Situation and Trends
3.8.1 Antivirals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Antivirals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTIVIRALS INDUSTRY CHAIN ANALYSIS
4.1 Antivirals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIVIRALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Antivirals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Antivirals Market
5.7 ESG Ratings of Leading Companies
6 ANTIVIRALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antivirals Sales Market Share by Type (2020-2025)
6.3 Global Antivirals Market Size Market Share by Type (2020-2025)
6.4 Global Antivirals Price by Type (2020-2025)
7 ANTIVIRALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antivirals Market Sales by Application (2020-2025)
7.3 Global Antivirals Market Size (M USD) by Application (2020-2025)
7.4 Global Antivirals Sales Growth Rate by Application (2020-2025)
8 ANTIVIRALS MARKET SALES BY REGION
8.1 Global Antivirals Sales by Region
8.1.1 Global Antivirals Sales by Region
8.1.2 Global Antivirals Sales Market Share by Region
8.2 Global Antivirals Market Size by Region
8.2.1 Global Antivirals Market Size by Region
8.2.2 Global Antivirals Market Size Market Share by Region
8.3 North America
8.3.1 North America Antivirals Sales by Country
8.3.2 North America Antivirals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Antivirals Sales by Country
8.4.2 Europe Antivirals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Antivirals Sales by Region
8.5.2 Asia Pacific Antivirals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Antivirals Sales by Country
8.6.2 South America Antivirals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Antivirals Sales by Region
8.7.2 Middle East and Africa Antivirals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTIVIRALS MARKET PRODUCTION BY REGION
9.1 Global Production of Antivirals by Region(2020-2025)
9.2 Global Antivirals Revenue Market Share by Region (2020-2025)
9.3 Global Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antivirals Production
9.4.1 North America Antivirals Production Growth Rate (2020-2025)
9.4.2 North America Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antivirals Production
9.5.1 Europe Antivirals Production Growth Rate (2020-2025)
9.5.2 Europe Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antivirals Production (2020-2025)
9.6.1 Japan Antivirals Production Growth Rate (2020-2025)
9.6.2 Japan Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antivirals Production (2020-2025)
9.7.1 China Antivirals Production Growth Rate (2020-2025)
9.7.2 China Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Antivirals Product Overview
10.1.3 Merck Antivirals Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Basic Information
10.2.2 Johnson and Johnson Antivirals Product Overview
10.2.3 Johnson and Johnson Antivirals Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 Teva Pharmaceutical Industries
10.3.1 Teva Pharmaceutical Industries Basic Information
10.3.2 Teva Pharmaceutical Industries Antivirals Product Overview
10.3.3 Teva Pharmaceutical Industries Antivirals Product Market Performance
10.3.4 Teva Pharmaceutical Industries Business Overview
10.3.5 Teva Pharmaceutical Industries SWOT Analysis
10.3.6 Teva Pharmaceutical Industries Recent Developments
10.4 GSK
10.4.1 GSK Basic Information
10.4.2 GSK Antivirals Product Overview
10.4.3 GSK Antivirals Product Market Performance
10.4.4 GSK Business Overview
10.4.5 GSK Recent Developments
10.5 Mylan
10.5.1 Mylan Basic Information
10.5.2 Mylan Antivirals Product Overview
10.5.3 Mylan Antivirals Product Market Performance
10.5.4 Mylan Business Overview
10.5.5 Mylan Recent Developments
10.6 Gilead Sciences
10.6.1 Gilead Sciences Basic Information
10.6.2 Gilead Sciences Antivirals Product Overview
10.6.3 Gilead Sciences Antivirals Product Market Performance
10.6.4 Gilead Sciences Business Overview
10.6.5 Gilead Sciences Recent Developments
10.7 F. Hoffmann-La Roche
10.7.1 F. Hoffmann-La Roche Basic Information
10.7.2 F. Hoffmann-La Roche Antivirals Product Overview
10.7.3 F. Hoffmann-La Roche Antivirals Product Market Performance
10.7.4 F. Hoffmann-La Roche Business Overview
10.7.5 F. Hoffmann-La Roche Recent Developments
10.8 Bristol-Myers-Squibb
10.8.1 Bristol-Myers-Squibb Basic Information
10.8.2 Bristol-Myers-Squibb Antivirals Product Overview
10.8.3 Bristol-Myers-Squibb Antivirals Product Market Performance
10.8.4 Bristol-Myers-Squibb Business Overview
10.8.5 Bristol-Myers-Squibb Recent Developments
10.9 AbbVie
10.9.1 AbbVie Basic Information
10.9.2 AbbVie Antivirals Product Overview
10.9.3 AbbVie Antivirals Product Market Performance
10.9.4 AbbVie Business Overview
10.9.5 AbbVie Recent Developments
10.10 Aurobindo Pharma
10.10.1 Aurobindo Pharma Basic Information
10.10.2 Aurobindo Pharma Antivirals Product Overview
10.10.3 Aurobindo Pharma Antivirals Product Market Performance
10.10.4 Aurobindo Pharma Business Overview
10.10.5 Aurobindo Pharma Recent Developments
10.11 Cipla
10.11.1 Cipla Basic Information
10.11.2 Cipla Antivirals Product Overview
10.11.3 Cipla Antivirals Product Market Performance
10.11.4 Cipla Business Overview
10.11.5 Cipla Recent Developments
10.12 Dr Reddy?s
10.12.1 Dr Reddy?s Basic Information
10.12.2 Dr Reddy?s Antivirals Product Overview
10.12.3 Dr Reddy?s Antivirals Product Market Performance
10.12.4 Dr Reddy?s Business Overview
10.12.5 Dr Reddy?s Recent Developments
11 ANTIVIRALS MARKET FORECAST BY REGION
11.1 Global Antivirals Market Size Forecast
11.2 Global Antivirals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antivirals Market Size Forecast by Country
11.2.3 Asia Pacific Antivirals Market Size Forecast by Region
11.2.4 South America Antivirals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Antivirals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Antivirals Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Antivirals by Type (2026-2033)
12.1.2 Global Antivirals Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Antivirals by Type (2026-2033)
12.2 Global Antivirals Market Forecast by Application (2026-2033)
12.2.1 Global Antivirals Sales (K MT) Forecast by Application
12.2.2 Global Antivirals Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antivirals
1.2 Key Market Segments
1.2.1 Antivirals Segment by Type
1.2.2 Antivirals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTIVIRALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antivirals Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Antivirals Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTIVIRALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Antivirals Product Life Cycle
3.3 Global Antivirals Sales by Manufacturers (2020-2025)
3.4 Global Antivirals Revenue Market Share by Manufacturers (2020-2025)
3.5 Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Antivirals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Antivirals Market Competitive Situation and Trends
3.8.1 Antivirals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Antivirals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ANTIVIRALS INDUSTRY CHAIN ANALYSIS
4.1 Antivirals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTIVIRALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Antivirals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Antivirals Market
5.7 ESG Ratings of Leading Companies
6 ANTIVIRALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antivirals Sales Market Share by Type (2020-2025)
6.3 Global Antivirals Market Size Market Share by Type (2020-2025)
6.4 Global Antivirals Price by Type (2020-2025)
7 ANTIVIRALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antivirals Market Sales by Application (2020-2025)
7.3 Global Antivirals Market Size (M USD) by Application (2020-2025)
7.4 Global Antivirals Sales Growth Rate by Application (2020-2025)
8 ANTIVIRALS MARKET SALES BY REGION
8.1 Global Antivirals Sales by Region
8.1.1 Global Antivirals Sales by Region
8.1.2 Global Antivirals Sales Market Share by Region
8.2 Global Antivirals Market Size by Region
8.2.1 Global Antivirals Market Size by Region
8.2.2 Global Antivirals Market Size Market Share by Region
8.3 North America
8.3.1 North America Antivirals Sales by Country
8.3.2 North America Antivirals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Antivirals Sales by Country
8.4.2 Europe Antivirals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Antivirals Sales by Region
8.5.2 Asia Pacific Antivirals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Antivirals Sales by Country
8.6.2 South America Antivirals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Antivirals Sales by Region
8.7.2 Middle East and Africa Antivirals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ANTIVIRALS MARKET PRODUCTION BY REGION
9.1 Global Production of Antivirals by Region(2020-2025)
9.2 Global Antivirals Revenue Market Share by Region (2020-2025)
9.3 Global Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Antivirals Production
9.4.1 North America Antivirals Production Growth Rate (2020-2025)
9.4.2 North America Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Antivirals Production
9.5.1 Europe Antivirals Production Growth Rate (2020-2025)
9.5.2 Europe Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Antivirals Production (2020-2025)
9.6.1 Japan Antivirals Production Growth Rate (2020-2025)
9.6.2 Japan Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Antivirals Production (2020-2025)
9.7.1 China Antivirals Production Growth Rate (2020-2025)
9.7.2 China Antivirals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Antivirals Product Overview
10.1.3 Merck Antivirals Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Johnson and Johnson
10.2.1 Johnson and Johnson Basic Information
10.2.2 Johnson and Johnson Antivirals Product Overview
10.2.3 Johnson and Johnson Antivirals Product Market Performance
10.2.4 Johnson and Johnson Business Overview
10.2.5 Johnson and Johnson SWOT Analysis
10.2.6 Johnson and Johnson Recent Developments
10.3 Teva Pharmaceutical Industries
10.3.1 Teva Pharmaceutical Industries Basic Information
10.3.2 Teva Pharmaceutical Industries Antivirals Product Overview
10.3.3 Teva Pharmaceutical Industries Antivirals Product Market Performance
10.3.4 Teva Pharmaceutical Industries Business Overview
10.3.5 Teva Pharmaceutical Industries SWOT Analysis
10.3.6 Teva Pharmaceutical Industries Recent Developments
10.4 GSK
10.4.1 GSK Basic Information
10.4.2 GSK Antivirals Product Overview
10.4.3 GSK Antivirals Product Market Performance
10.4.4 GSK Business Overview
10.4.5 GSK Recent Developments
10.5 Mylan
10.5.1 Mylan Basic Information
10.5.2 Mylan Antivirals Product Overview
10.5.3 Mylan Antivirals Product Market Performance
10.5.4 Mylan Business Overview
10.5.5 Mylan Recent Developments
10.6 Gilead Sciences
10.6.1 Gilead Sciences Basic Information
10.6.2 Gilead Sciences Antivirals Product Overview
10.6.3 Gilead Sciences Antivirals Product Market Performance
10.6.4 Gilead Sciences Business Overview
10.6.5 Gilead Sciences Recent Developments
10.7 F. Hoffmann-La Roche
10.7.1 F. Hoffmann-La Roche Basic Information
10.7.2 F. Hoffmann-La Roche Antivirals Product Overview
10.7.3 F. Hoffmann-La Roche Antivirals Product Market Performance
10.7.4 F. Hoffmann-La Roche Business Overview
10.7.5 F. Hoffmann-La Roche Recent Developments
10.8 Bristol-Myers-Squibb
10.8.1 Bristol-Myers-Squibb Basic Information
10.8.2 Bristol-Myers-Squibb Antivirals Product Overview
10.8.3 Bristol-Myers-Squibb Antivirals Product Market Performance
10.8.4 Bristol-Myers-Squibb Business Overview
10.8.5 Bristol-Myers-Squibb Recent Developments
10.9 AbbVie
10.9.1 AbbVie Basic Information
10.9.2 AbbVie Antivirals Product Overview
10.9.3 AbbVie Antivirals Product Market Performance
10.9.4 AbbVie Business Overview
10.9.5 AbbVie Recent Developments
10.10 Aurobindo Pharma
10.10.1 Aurobindo Pharma Basic Information
10.10.2 Aurobindo Pharma Antivirals Product Overview
10.10.3 Aurobindo Pharma Antivirals Product Market Performance
10.10.4 Aurobindo Pharma Business Overview
10.10.5 Aurobindo Pharma Recent Developments
10.11 Cipla
10.11.1 Cipla Basic Information
10.11.2 Cipla Antivirals Product Overview
10.11.3 Cipla Antivirals Product Market Performance
10.11.4 Cipla Business Overview
10.11.5 Cipla Recent Developments
10.12 Dr Reddy?s
10.12.1 Dr Reddy?s Basic Information
10.12.2 Dr Reddy?s Antivirals Product Overview
10.12.3 Dr Reddy?s Antivirals Product Market Performance
10.12.4 Dr Reddy?s Business Overview
10.12.5 Dr Reddy?s Recent Developments
11 ANTIVIRALS MARKET FORECAST BY REGION
11.1 Global Antivirals Market Size Forecast
11.2 Global Antivirals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Antivirals Market Size Forecast by Country
11.2.3 Asia Pacific Antivirals Market Size Forecast by Region
11.2.4 South America Antivirals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Antivirals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Antivirals Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Antivirals by Type (2026-2033)
12.1.2 Global Antivirals Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Antivirals by Type (2026-2033)
12.2 Global Antivirals Market Forecast by Application (2026-2033)
12.2.1 Global Antivirals Sales (K MT) Forecast by Application
12.2.2 Global Antivirals Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antivirals Market Size Comparison by Region (M USD)
Table 5. Global Antivirals Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Antivirals Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Antivirals Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Antivirals Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivirals as of 2024)
Table 10. Global Market Antivirals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Antivirals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Antivirals Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Antivirals Sales by Type (K MT)
Table 26. Global Antivirals Market Size by Type (M USD)
Table 27. Global Antivirals Sales (K MT) by Type (2020-2025)
Table 28. Global Antivirals Sales Market Share by Type (2020-2025)
Table 29. Global Antivirals Market Size (M USD) by Type (2020-2025)
Table 30. Global Antivirals Market Size Share by Type (2020-2025)
Table 31. Global Antivirals Price (USD/KG) by Type (2020-2025)
Table 32. Global Antivirals Sales (K MT) by Application
Table 33. Global Antivirals Market Size by Application
Table 34. Global Antivirals Sales by Application (2020-2025) & (K MT)
Table 35. Global Antivirals Sales Market Share by Application (2020-2025)
Table 36. Global Antivirals Market Size by Application (2020-2025) & (M USD)
Table 37. Global Antivirals Market Share by Application (2020-2025)
Table 38. Global Antivirals Sales Growth Rate by Application (2020-2025)
Table 39. Global Antivirals Sales by Region (2020-2025) & (K MT)
Table 40. Global Antivirals Sales Market Share by Region (2020-2025)
Table 41. Global Antivirals Market Size by Region (2020-2025) & (M USD)
Table 42. Global Antivirals Market Size Market Share by Region (2020-2025)
Table 43. North America Antivirals Sales by Country (2020-2025) & (K MT)
Table 44. North America Antivirals Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Antivirals Sales by Country (2020-2025) & (K MT)
Table 46. Europe Antivirals Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Antivirals Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Antivirals Market Size by Region (2020-2025) & (M USD)
Table 49. South America Antivirals Sales by Country (2020-2025) & (K MT)
Table 50. South America Antivirals Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Antivirals Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Antivirals Market Size by Region (2020-2025) & (M USD)
Table 53. Global Antivirals Production (K MT) by Region(2020-2025)
Table 54. Global Antivirals Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Antivirals Revenue Market Share by Region (2020-2025)
Table 56. Global Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Antivirals Product Overview
Table 63. Merck Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. Johnson and Johnson Basic Information
Table 68. Johnson and Johnson Antivirals Product Overview
Table 69. Johnson and Johnson Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Johnson and Johnson Business Overview
Table 71. Johnson and Johnson SWOT Analysis
Table 72. Johnson and Johnson Recent Developments
Table 73. Teva Pharmaceutical Industries Basic Information
Table 74. Teva Pharmaceutical Industries Antivirals Product Overview
Table 75. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Teva Pharmaceutical Industries Business Overview
Table 77. Teva Pharmaceutical Industries SWOT Analysis
Table 78. Teva Pharmaceutical Industries Recent Developments
Table 79. GSK Basic Information
Table 80. GSK Antivirals Product Overview
Table 81. GSK Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. GSK Business Overview
Table 83. GSK Recent Developments
Table 84. Mylan Basic Information
Table 85. Mylan Antivirals Product Overview
Table 86. Mylan Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Mylan Business Overview
Table 88. Mylan Recent Developments
Table 89. Gilead Sciences Basic Information
Table 90. Gilead Sciences Antivirals Product Overview
Table 91. Gilead Sciences Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Recent Developments
Table 94. F. Hoffmann-La Roche Basic Information
Table 95. F. Hoffmann-La Roche Antivirals Product Overview
Table 96. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. F. Hoffmann-La Roche Business Overview
Table 98. F. Hoffmann-La Roche Recent Developments
Table 99. Bristol-Myers-Squibb Basic Information
Table 100. Bristol-Myers-Squibb Antivirals Product Overview
Table 101. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Bristol-Myers-Squibb Business Overview
Table 103. Bristol-Myers-Squibb Recent Developments
Table 104. AbbVie Basic Information
Table 105. AbbVie Antivirals Product Overview
Table 106. AbbVie Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. AbbVie Business Overview
Table 108. AbbVie Recent Developments
Table 109. Aurobindo Pharma Basic Information
Table 110. Aurobindo Pharma Antivirals Product Overview
Table 111. Aurobindo Pharma Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Aurobindo Pharma Business Overview
Table 113. Aurobindo Pharma Recent Developments
Table 114. Cipla Basic Information
Table 115. Cipla Antivirals Product Overview
Table 116. Cipla Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Cipla Business Overview
Table 118. Cipla Recent Developments
Table 119. Dr Reddy?s Basic Information
Table 120. Dr Reddy?s Antivirals Product Overview
Table 121. Dr Reddy?s Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Dr Reddy?s Business Overview
Table 123. Dr Reddy?s Recent Developments
Table 124. Global Antivirals Sales Forecast by Region (2026-2033) & (K MT)
Table 125. Global Antivirals Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Antivirals Sales Forecast by Country (2026-2033) & (K MT)
Table 127. North America Antivirals Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Antivirals Sales Forecast by Country (2026-2033) & (K MT)
Table 129. Europe Antivirals Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Antivirals Sales Forecast by Region (2026-2033) & (K MT)
Table 131. Asia Pacific Antivirals Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Antivirals Sales Forecast by Country (2026-2033) & (K MT)
Table 133. South America Antivirals Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Antivirals Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Antivirals Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Antivirals Sales Forecast by Type (2026-2033) & (K MT)
Table 137. Global Antivirals Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Antivirals Price Forecast by Type (2026-2033) & (USD/KG)
Table 139. Global Antivirals Sales (K MT) Forecast by Application (2026-2033)
Table 140. Global Antivirals Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antivirals Market Size Comparison by Region (M USD)
Table 5. Global Antivirals Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Antivirals Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Antivirals Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Antivirals Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antivirals as of 2024)
Table 10. Global Market Antivirals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Antivirals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Antivirals Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Antivirals Sales by Type (K MT)
Table 26. Global Antivirals Market Size by Type (M USD)
Table 27. Global Antivirals Sales (K MT) by Type (2020-2025)
Table 28. Global Antivirals Sales Market Share by Type (2020-2025)
Table 29. Global Antivirals Market Size (M USD) by Type (2020-2025)
Table 30. Global Antivirals Market Size Share by Type (2020-2025)
Table 31. Global Antivirals Price (USD/KG) by Type (2020-2025)
Table 32. Global Antivirals Sales (K MT) by Application
Table 33. Global Antivirals Market Size by Application
Table 34. Global Antivirals Sales by Application (2020-2025) & (K MT)
Table 35. Global Antivirals Sales Market Share by Application (2020-2025)
Table 36. Global Antivirals Market Size by Application (2020-2025) & (M USD)
Table 37. Global Antivirals Market Share by Application (2020-2025)
Table 38. Global Antivirals Sales Growth Rate by Application (2020-2025)
Table 39. Global Antivirals Sales by Region (2020-2025) & (K MT)
Table 40. Global Antivirals Sales Market Share by Region (2020-2025)
Table 41. Global Antivirals Market Size by Region (2020-2025) & (M USD)
Table 42. Global Antivirals Market Size Market Share by Region (2020-2025)
Table 43. North America Antivirals Sales by Country (2020-2025) & (K MT)
Table 44. North America Antivirals Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Antivirals Sales by Country (2020-2025) & (K MT)
Table 46. Europe Antivirals Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Antivirals Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Antivirals Market Size by Region (2020-2025) & (M USD)
Table 49. South America Antivirals Sales by Country (2020-2025) & (K MT)
Table 50. South America Antivirals Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Antivirals Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Antivirals Market Size by Region (2020-2025) & (M USD)
Table 53. Global Antivirals Production (K MT) by Region(2020-2025)
Table 54. Global Antivirals Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Antivirals Revenue Market Share by Region (2020-2025)
Table 56. Global Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Antivirals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Merck Basic Information
Table 62. Merck Antivirals Product Overview
Table 63. Merck Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Merck Business Overview
Table 65. Merck SWOT Analysis
Table 66. Merck Recent Developments
Table 67. Johnson and Johnson Basic Information
Table 68. Johnson and Johnson Antivirals Product Overview
Table 69. Johnson and Johnson Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Johnson and Johnson Business Overview
Table 71. Johnson and Johnson SWOT Analysis
Table 72. Johnson and Johnson Recent Developments
Table 73. Teva Pharmaceutical Industries Basic Information
Table 74. Teva Pharmaceutical Industries Antivirals Product Overview
Table 75. Teva Pharmaceutical Industries Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. Teva Pharmaceutical Industries Business Overview
Table 77. Teva Pharmaceutical Industries SWOT Analysis
Table 78. Teva Pharmaceutical Industries Recent Developments
Table 79. GSK Basic Information
Table 80. GSK Antivirals Product Overview
Table 81. GSK Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. GSK Business Overview
Table 83. GSK Recent Developments
Table 84. Mylan Basic Information
Table 85. Mylan Antivirals Product Overview
Table 86. Mylan Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Mylan Business Overview
Table 88. Mylan Recent Developments
Table 89. Gilead Sciences Basic Information
Table 90. Gilead Sciences Antivirals Product Overview
Table 91. Gilead Sciences Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Gilead Sciences Business Overview
Table 93. Gilead Sciences Recent Developments
Table 94. F. Hoffmann-La Roche Basic Information
Table 95. F. Hoffmann-La Roche Antivirals Product Overview
Table 96. F. Hoffmann-La Roche Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. F. Hoffmann-La Roche Business Overview
Table 98. F. Hoffmann-La Roche Recent Developments
Table 99. Bristol-Myers-Squibb Basic Information
Table 100. Bristol-Myers-Squibb Antivirals Product Overview
Table 101. Bristol-Myers-Squibb Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Bristol-Myers-Squibb Business Overview
Table 103. Bristol-Myers-Squibb Recent Developments
Table 104. AbbVie Basic Information
Table 105. AbbVie Antivirals Product Overview
Table 106. AbbVie Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. AbbVie Business Overview
Table 108. AbbVie Recent Developments
Table 109. Aurobindo Pharma Basic Information
Table 110. Aurobindo Pharma Antivirals Product Overview
Table 111. Aurobindo Pharma Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Aurobindo Pharma Business Overview
Table 113. Aurobindo Pharma Recent Developments
Table 114. Cipla Basic Information
Table 115. Cipla Antivirals Product Overview
Table 116. Cipla Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Cipla Business Overview
Table 118. Cipla Recent Developments
Table 119. Dr Reddy?s Basic Information
Table 120. Dr Reddy?s Antivirals Product Overview
Table 121. Dr Reddy?s Antivirals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Dr Reddy?s Business Overview
Table 123. Dr Reddy?s Recent Developments
Table 124. Global Antivirals Sales Forecast by Region (2026-2033) & (K MT)
Table 125. Global Antivirals Market Size Forecast by Region (2026-2033) & (M USD)
Table 126. North America Antivirals Sales Forecast by Country (2026-2033) & (K MT)
Table 127. North America Antivirals Market Size Forecast by Country (2026-2033) & (M USD)
Table 128. Europe Antivirals Sales Forecast by Country (2026-2033) & (K MT)
Table 129. Europe Antivirals Market Size Forecast by Country (2026-2033) & (M USD)
Table 130. Asia Pacific Antivirals Sales Forecast by Region (2026-2033) & (K MT)
Table 131. Asia Pacific Antivirals Market Size Forecast by Region (2026-2033) & (M USD)
Table 132. South America Antivirals Sales Forecast by Country (2026-2033) & (K MT)
Table 133. South America Antivirals Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Middle East and Africa Antivirals Sales Forecast by Country (2026-2033) & (Units)
Table 135. Middle East and Africa Antivirals Market Size Forecast by Country (2026-2033) & (M USD)
Table 136. Global Antivirals Sales Forecast by Type (2026-2033) & (K MT)
Table 137. Global Antivirals Market Size Forecast by Type (2026-2033) & (M USD)
Table 138. Global Antivirals Price Forecast by Type (2026-2033) & (USD/KG)
Table 139. Global Antivirals Sales (K MT) Forecast by Application (2026-2033)
Table 140. Global Antivirals Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antivirals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antivirals Market Size (M USD), 2024-2033
Figure 5. Global Antivirals Market Size (M USD) (2020-2033)
Figure 6. Global Antivirals Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antivirals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antivirals Product Life Cycle
Figure 13. Antivirals Sales Share by Manufacturers in 2024
Figure 14. Global Antivirals Revenue Share by Manufacturers in 2024
Figure 15. Antivirals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Antivirals Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antivirals Revenue in 2024
Figure 18. Industry Chain Map of Antivirals
Figure 19. Global Antivirals Market PEST Analysis
Figure 20. Global Antivirals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antivirals Market Share by Type
Figure 27. Sales Market Share of Antivirals by Type (2020-2025)
Figure 28. Sales Market Share of Antivirals by Type in 2024
Figure 29. Market Size Share of Antivirals by Type (2020-2025)
Figure 30. Market Size Share of Antivirals by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antivirals Market Share by Application
Figure 33. Global Antivirals Sales Market Share by Application (2020-2025)
Figure 34. Global Antivirals Sales Market Share by Application in 2024
Figure 35. Global Antivirals Market Share by Application (2020-2025)
Figure 36. Global Antivirals Market Share by Application in 2024
Figure 37. Global Antivirals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antivirals Sales Market Share by Region (2020-2025)
Figure 39. Global Antivirals Market Size Market Share by Region (2020-2025)
Figure 40. North America Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antivirals Sales Market Share by Country in 2024
Figure 43. North America Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antivirals Market Size Market Share by Country in 2024
Figure 45. U.S. Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antivirals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antivirals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antivirals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antivirals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antivirals Sales Market Share by Country in 2024
Figure 53. Europe Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antivirals Market Size Market Share by Country in 2024
Figure 55. Germany Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antivirals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antivirals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antivirals Market Size Market Share by Region in 2024
Figure 68. China Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antivirals Sales and Growth Rate (K MT)
Figure 79. South America Antivirals Sales Market Share by Country in 2024
Figure 80. South America Antivirals Market Size and Growth Rate (M USD)
Figure 81. South America Antivirals Market Size Market Share by Country in 2024
Figure 82. Brazil Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antivirals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antivirals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antivirals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antivirals Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antivirals Production Market Share by Region (2020-2025)
Figure 103. North America Antivirals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antivirals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antivirals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antivirals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antivirals Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Antivirals Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Antivirals Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Antivirals Market Share Forecast by Type (2026-2033)
Figure 111. Global Antivirals Sales Forecast by Application (2026-2033)
Figure 112. Global Antivirals Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Antivirals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antivirals Market Size (M USD), 2024-2033
Figure 5. Global Antivirals Market Size (M USD) (2020-2033)
Figure 6. Global Antivirals Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antivirals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Antivirals Product Life Cycle
Figure 13. Antivirals Sales Share by Manufacturers in 2024
Figure 14. Global Antivirals Revenue Share by Manufacturers in 2024
Figure 15. Antivirals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Antivirals Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Antivirals Revenue in 2024
Figure 18. Industry Chain Map of Antivirals
Figure 19. Global Antivirals Market PEST Analysis
Figure 20. Global Antivirals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Antivirals Market Share by Type
Figure 27. Sales Market Share of Antivirals by Type (2020-2025)
Figure 28. Sales Market Share of Antivirals by Type in 2024
Figure 29. Market Size Share of Antivirals by Type (2020-2025)
Figure 30. Market Size Share of Antivirals by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Antivirals Market Share by Application
Figure 33. Global Antivirals Sales Market Share by Application (2020-2025)
Figure 34. Global Antivirals Sales Market Share by Application in 2024
Figure 35. Global Antivirals Market Share by Application (2020-2025)
Figure 36. Global Antivirals Market Share by Application in 2024
Figure 37. Global Antivirals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Antivirals Sales Market Share by Region (2020-2025)
Figure 39. Global Antivirals Market Size Market Share by Region (2020-2025)
Figure 40. North America Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Antivirals Sales Market Share by Country in 2024
Figure 43. North America Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Antivirals Market Size Market Share by Country in 2024
Figure 45. U.S. Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Antivirals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Antivirals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Antivirals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Antivirals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Antivirals Sales Market Share by Country in 2024
Figure 53. Europe Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Antivirals Market Size Market Share by Country in 2024
Figure 55. Germany Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Antivirals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Antivirals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Antivirals Market Size Market Share by Region in 2024
Figure 68. China Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Antivirals Sales and Growth Rate (K MT)
Figure 79. South America Antivirals Sales Market Share by Country in 2024
Figure 80. South America Antivirals Market Size and Growth Rate (M USD)
Figure 81. South America Antivirals Market Size Market Share by Country in 2024
Figure 82. Brazil Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Antivirals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Antivirals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Antivirals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Antivirals Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Antivirals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Antivirals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Antivirals Production Market Share by Region (2020-2025)
Figure 103. North America Antivirals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Antivirals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Antivirals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Antivirals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Antivirals Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Antivirals Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Antivirals Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Antivirals Market Share Forecast by Type (2026-2033)
Figure 111. Global Antivirals Sales Forecast by Application (2026-2033)
Figure 112. Global Antivirals Market Share Forecast by Application (2026-2033)
